2025 Agenda

Work smarter not harder: cancer care pathway mapping to drive more effective service redesign

11 Jun 2025
Exchange 8-10
Cancer , Mobilising change / improvement

NHS cancer services are under increasing pressures right across the UK, and with limited additional resources becoming available coupled with the arrival of more innovative and complex treatments, there needs to be a fundamental rethink on how many of these services are designed to ensure they are future fit.

This session will showcase case studies from The Clatterbridge Centre, The Christie and Belfast Health and Social Care Trust, where pathway mapping within the breast cancer service uncovered hidden blocks within the system.

Our experts will discuss how the outcomes resulted in a mindset shift on where pathway efficiencies needed to be made to make the greatest impact on the service overall.

Attendees will gain:
• first-hand insights into how pathway mapping can reveal unseen challenges
• practical strategies for identifying and addressing inefficiencies in cancer services
• inspiration and actionable ideas to take back to their own healthcare settings.

This session is supported by Novartis UK. This non-promotional session has been organised and fully funded by Novartis Pharmaceuticals UK Ltd.

Amit Aggarwal
Dr Amit Aggarwal, Executive Director Medical Affairs & Strategic Partnerships - The Association of the British Pharmaceutical Industry
Kyle Crawford
Kyle Crawford - Belfast Health and Social Care Trust
Chelcie Faulkner
Chelcie Faulkner, Metastatic Breast Cancer Clinical Nurse Specialist - The Clatterbridge Cancer Centre NHS Foundation Trust
Claire Goldrick
Claire Goldrick, Pathway Manager for Breast, Neuro-oncology and Research - Greater Manchester Cancer Alliance

Supported by:

 Novartis UK